Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain.
about
The importance of integrating basic and clinical research toward the development of new therapies for Huntington diseaseA spectral analysis approach for determination of regional rates of cerebral protein synthesis with the L-[1-(11)C]leucine PET method.Xanthines as adenosine receptor antagonists.Pathophysiological roles for purines: adenosine, caffeine and urate.Adenosine A₂a receptors and O₂ sensing in developmentAdenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease.Novel therapy in Parkinson's disease: adenosine A(2A) receptor antagonists.New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors.Adenosine A2A antagonists in Parkinson's disease: what's next?Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant.Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued.Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging.Test-retest variability of adenosine A2A binding in the human brain with (11)C-TMSX and PET.Istradefylline: first global approval.Population pharmacokinetic-pharmacodynamic analysis of istradefylline in patients with Parkinson disease.In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease.In vivo evaluation of [11C]preladenant positron emission tomography for quantification of adenosine A2A receptors in the rat brain.
P2860
Q22306292-AF768B01-6C94-48E9-B0CD-E0511D8D0717Q34009095-D1A5B3D8-E20E-41D2-A3BE-DF81CCF94924Q34139398-2C3B5F2F-EC6F-4C5B-A75A-BDB4E2B35071Q35008049-E1B3DED9-C59E-4547-A002-6F73BFB23F6BQ35217420-74E2A889-9B2F-41E8-A989-6632DEB6F2AAQ37348458-0E32151F-B293-4CCE-B5CF-A4F3C71EE50CQ37844573-AAFE9603-8067-494C-9248-A65DD9863F52Q37974709-B0BE186F-89A4-4945-9BB8-0F8EFCD4B61BQ38010070-C57E09A7-4B48-4B19-B6DA-B8F0A89FEF59Q38199744-EE353CDE-5C68-42B2-A0AD-62CBFC9ACA9DQ38200930-4A8E76D2-7FB8-4985-A0F2-0D204B4A8EAEQ38765118-4A4FBD34-E4B0-4B8D-B9DF-61FB7C533DECQ43104979-B8C28632-C790-418D-AE39-2CE28FECD80DQ44360692-D75DEBA9-ECA6-47A1-A6BA-948CD13840B8Q46168372-FF20659F-45CD-4078-B221-7E59DCB31ABEQ47853027-7F266F4B-4DCA-4BAC-8112-26D6B7926C41Q48876822-5E9E733C-01BB-4D87-A805-8D7551E568C8
P2860
Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Positron emission tomography a ...... ne A2A receptors in the brain.
@en
Positron emission tomography a ...... ne A2A receptors in the brain.
@nl
type
label
Positron emission tomography a ...... ne A2A receptors in the brain.
@en
Positron emission tomography a ...... ne A2A receptors in the brain.
@nl
prefLabel
Positron emission tomography a ...... ne A2A receptors in the brain.
@en
Positron emission tomography a ...... ne A2A receptors in the brain.
@nl
P2093
P2860
P356
P1433
P1476
Positron emission tomography a ...... ne A2A receptors in the brain.
@en
P2093
S K Luthra
S Martindill
P2860
P304
P356
10.1002/SYN.20539
P577
2008-09-01T00:00:00Z